Proactive Health Initiative MyOme's launch of the Proactive Health Network demonstrates a strategic shift toward personalized, prevention-based healthcare. This initiative presents opportunities to partner with concierge, executive health, and longevity clinics aiming to offer advanced genomic services for proactive health management.

Expanding Rare Disease Portfolio The release of MyOme's Rare Disease product portfolio and active participation in ACMG 2025 indicate a focus on niche genetic testing markets. Sales efforts can target genetic counselors and clinics specializing in rare diseases to expand utilization of these specialized genomic tests.

Strong Industry Partnerships Strategic collaborations with Novi Health highlight MyOme’s interest in integrated and personalized healthcare solutions. Collaborating with healthcare providers and preventative care platforms can enhance market penetration and create joint offerings for personalized treatment plans.

Technological Expertise Utilizing advanced bioinformatics, whole genome sequencing, and polygenic risk modeling positions MyOme as a provider of high-tech, clinically actionable insights. This creates opportunities to sell to healthcare organizations seeking sophisticated genomic solutions for personalized medicine and risk stratification.